104420042
commented on
$Verrica Pharmaceuticals (VRCA.US)$
Verrica Pharmaceuticals Announces that Development Partner Torii Pharmaceutical Files New Drug Application of TO-208 the Treatment of Molluscum Contagiosum in Japan
Friday, 6th December at 8:00 am
WEST CHESTER, Pa., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. ("Verrica" or the "Company") (NASDAQ: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced its develop...
Verrica Pharmaceuticals Announces that Development Partner Torii Pharmaceutical Files New Drug Application of TO-208 the Treatment of Molluscum Contagiosum in Japan
Friday, 6th December at 8:00 am
WEST CHESTER, Pa., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. ("Verrica" or the "Company") (NASDAQ: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced its develop...
3
104420042
commented on
1
7
104420042
commented on
$Verrica Pharmaceuticals (VRCA.US)$
Verrica Pharmaceuticals Announces Restructuring of Commercial Organization
Company significantly reduces cost structure with a realigned sales, marketing and operational infrastructure
- Sales and marketing efforts to focus on pediatricians and expand access beyond dermatologists
WEST CHESTER, Pa., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. ("Verrica" or the "Company") (NASDAQ:VRCA), a dermatology therapeutics company developing med...
Verrica Pharmaceuticals Announces Restructuring of Commercial Organization
Company significantly reduces cost structure with a realigned sales, marketing and operational infrastructure
- Sales and marketing efforts to focus on pediatricians and expand access beyond dermatologists
WEST CHESTER, Pa., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. ("Verrica" or the "Company") (NASDAQ:VRCA), a dermatology therapeutics company developing med...
1
104420042
commented on
$Verrica Pharmaceuticals (VRCA.US)$ looks like the bottom
1
104420042
commented on and voted
I feel that this rate cut against an uncertain recessionary and un/under-employment backdrop, on top other bad govermental policies = volatility. To add to this, there is too much hot money in the market, not just from US investors/ traders, but from all over the world, further contributing to the chaos.
My current strategy is defensive.
1) 50% of my portfolio is high dividend stock such as:
$Stellantis NV (STLA.US)$
$GlaxoSmithKline (GSK.US)$
$Ecopetrol (EC.US)$
My current strategy is defensive.
1) 50% of my portfolio is high dividend stock such as:
$Stellantis NV (STLA.US)$
$GlaxoSmithKline (GSK.US)$
$Ecopetrol (EC.US)$
104420042 : drop to floor already guys